(Q41921463)

14 October 2017

Halofantrine and chloroquine inhibit CYP2D6 activity in healthy Zambians (English)

1 reference

14 October 2017

0 references

0 references

1 reference

O O Simooya

1

1 reference

14 October 2017

G Sijumbil

series ordinal

2

1 reference

14 October 2017

M S Lennard

series ordinal

3

1 reference

14 October 2017

G T Tucker

series ordinal

4

1 reference

14 October 2017

language of work or name

English

0 references

publication date

1 March 1998

1 reference

British Journal of Clinical Pharmacology

14 October 2017

1 reference

14 October 2017

45

1 reference

14 October 2017

3

1 reference

14 October 2017

315-317

1 reference

Clinical pharmacokinetics and metabolism of chloroquine. Focus on recent advancements

14 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1873379

Lack of effect of chloroquine on the debrisoquine (CYP2D6 and S-mephenytoin (CYP2C19) hydroxylation phenotypes

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1873379

An investigation of the interaction between halofantrine, CYP2D6 and CYP3A4: studies with human liver microsomes and heterologous enzyme expression systems

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1873379

Clinical implications of genetic polymorphism in drug metabolism

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1873379

Clinical pharmacokinetics of halofantrine

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1873379

Inhibitory effects of antiparasitic drugs on cytochrome P450 2D6.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1873379

The eosin colour test of Dill and Glazko: a simple field test to detect chloroquine in urine

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1873379

Genetic polymorphism of sparteine/debrisoquine oxidation: a reappraisal

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1873379

Inhibition of metoprolol metabolism by chloroquine and other antimalarial drugs

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1873379

A Multiple Comparison Procedure for Comparing Several Treatments with a Control

5 June 2018

1 reference

Crossref

https://api.crossref.org/works/10.1046%2FJ.1365-2125.1998.00671.X

Hydroxylation polymorphisms of debrisoquine and mephenytoin in European populations

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/10896408

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Genetic polymorphism of cytochrome P450 CYP2D6 in Zimbabwean population

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/10896408

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Determination of debrisoquine and its 4-hydroxy metabolite in biological fluids by gas chromatography with flame-ionization and nitrogen-selective detection

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/10896408

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1046/J.1365-2125.1998.00671.X

1 reference

14 October 2017

1 reference

14 October 2017

PubMed publication ID

10896408

1 reference